Serum sodium is associated with amyloid‐dependent tau pathology, neurodegeneration, and cognitive impairment in Alzheimer's disease
Serum sodium plays a crucial role in AD progression, revealing a potential network of sodium dysregulation in AD pathology. Targeting sodium may provide a novel therapeutic approach for slowing AD progression, particularly in impeding amyloid-related downstream events.
Authors
- Zhiqi Mao
- Yuhan Chen
Institutions
- Hebei North University (CN)
- Chinese PLA General Hospital (CN)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_101607
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00